FI81351C - Foerfarande foer framstaellning av farmakologiskt aktiva 2-pyridylsubstituerade 6,7-dihydro-3h,5h-pyrrolo/ 2,3-f/bentsimidazol-6-oner och -6-tioner. - Google Patents

Foerfarande foer framstaellning av farmakologiskt aktiva 2-pyridylsubstituerade 6,7-dihydro-3h,5h-pyrrolo/ 2,3-f/bentsimidazol-6-oner och -6-tioner. Download PDF

Info

Publication number
FI81351C
FI81351C FI851869A FI851869A FI81351C FI 81351 C FI81351 C FI 81351C FI 851869 A FI851869 A FI 851869A FI 851869 A FI851869 A FI 851869A FI 81351 C FI81351 C FI 81351C
Authority
FI
Finland
Prior art keywords
formula
compound
pyridyl
group
carboxylic acid
Prior art date
Application number
FI851869A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI851869L (fi
FI81351B (fi
FI851869A0 (fi
Inventor
Wolfgang Kampe
Klaus Strein
Alfred Mertens
Jens-Peter Hoelck
Bernd Muller-Beckmann
Gisbert Sponer
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19843417643 external-priority patent/DE3417643A1/de
Priority claimed from DE19843446417 external-priority patent/DE3446417A1/de
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of FI851869A0 publication Critical patent/FI851869A0/fi
Publication of FI851869L publication Critical patent/FI851869L/fi
Priority to FI883391A priority Critical patent/FI883391A/fi
Application granted granted Critical
Publication of FI81351B publication Critical patent/FI81351B/fi
Publication of FI81351C publication Critical patent/FI81351C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/96—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI851869A 1984-05-12 1985-05-10 Foerfarande foer framstaellning av farmakologiskt aktiva 2-pyridylsubstituerade 6,7-dihydro-3h,5h-pyrrolo/ 2,3-f/bentsimidazol-6-oner och -6-tioner. FI81351C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI883391A FI883391A (fi) 1984-05-12 1988-07-15 Saosom mellanprodukter anvaendbara indolinderivat.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19843417643 DE3417643A1 (de) 1984-05-12 1984-05-12 Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE3417643 1984-05-12
DE19843446417 DE3446417A1 (de) 1984-12-20 1984-12-20 Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE3446417 1984-12-20

Publications (4)

Publication Number Publication Date
FI851869A0 FI851869A0 (fi) 1985-05-10
FI851869L FI851869L (fi) 1985-11-13
FI81351B FI81351B (fi) 1990-06-29
FI81351C true FI81351C (fi) 1990-10-10

Family

ID=25821132

Family Applications (1)

Application Number Title Priority Date Filing Date
FI851869A FI81351C (fi) 1984-05-12 1985-05-10 Foerfarande foer framstaellning av farmakologiskt aktiva 2-pyridylsubstituerade 6,7-dihydro-3h,5h-pyrrolo/ 2,3-f/bentsimidazol-6-oner och -6-tioner.

Country Status (18)

Country Link
US (2) US4666923A (fr)
EP (1) EP0161632B1 (fr)
JP (2) JPH0647593B2 (fr)
KR (1) KR870001201B1 (fr)
AU (1) AU560349B2 (fr)
DE (1) DE3582447D1 (fr)
DK (1) DK209585A (fr)
ES (1) ES8603178A1 (fr)
FI (1) FI81351C (fr)
GR (1) GR851085B (fr)
HU (1) HU193754B (fr)
IL (1) IL75120A (fr)
NO (1) NO851862L (fr)
NZ (1) NZ212005A (fr)
PH (1) PH22863A (fr)
PL (2) PL144822B1 (fr)
PT (1) PT80425B (fr)
SU (1) SU1480770A3 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR851085B (fr) * 1984-05-12 1985-11-25 Boehringer Mannheim Gmbh
DE3445669A1 (de) * 1984-12-14 1986-06-19 Boehringer Mannheim Gmbh, 6800 Mannheim Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3501497A1 (de) * 1985-01-18 1986-07-24 Boehringer Mannheim Gmbh, 6800 Mannheim Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE3524067A1 (de) * 1985-07-05 1987-01-08 Boehringer Mannheim Gmbh Neue benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE3530825A1 (de) * 1985-08-29 1987-03-05 Boehringer Mannheim Gmbh Neue benzodipyrrole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3531678A1 (de) * 1985-09-05 1987-03-12 Boehringer Mannheim Gmbh Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3626664A1 (de) * 1986-08-07 1988-02-11 Boehringer Mannheim Gmbh Tricyclische benzotriazole, verfahren zu ihrer herstellung sowie arzneimittel
DE3639466A1 (de) * 1986-11-18 1988-05-19 Thomae Gmbh Dr K Neue pyrrolo-benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3642315A1 (de) * 1986-12-11 1988-06-23 Boehringer Mannheim Gmbh Neue pyrrolobenzimidazole, verfahren zu ihrer herstellung sowie arzneimittel
DE3740985A1 (de) * 1987-12-03 1989-06-15 Boehringer Mannheim Gmbh Verwendung linear anellierter tricyclen als hemmer der erythrozytenaggregation
US4963677A (en) * 1987-12-30 1990-10-16 Orion Corporation Ltd. Heterocyclic lactam compounds
EP0322746B1 (fr) * 1987-12-30 1996-05-29 Orion Corporation Limited Composés hétérocycliques
DE3803775A1 (de) * 1988-02-09 1989-08-17 Boehringer Mannheim Gmbh Neue substituierte lactame, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
US5324911A (en) * 1990-01-08 1994-06-28 Schroer Manufacturing Company Heated animal surgery table
DE4027592A1 (de) * 1990-08-31 1992-03-05 Beiersdorf Ag Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US20060142247A1 (en) * 2004-12-17 2006-06-29 Guy Georges Tricyclic heterocycles
AU2006233537A1 (en) * 2005-04-14 2006-10-19 F. Hoffmann-La Roche Ag Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents
WO2006108488A1 (fr) * 2005-04-14 2006-10-19 F. Hoffmann-La Roche Ag Derives d'azole tricycliques, leur fabrication et leur utilisation en tant que principes pharmaceutiques
EP1966213A1 (fr) * 2005-12-15 2008-09-10 F.Hoffmann-La Roche Ag Dérivés tricycliques de lactame, leur fabrication et leur emploi en tant qu'agents pharmaceutiques
JP2009530337A (ja) * 2006-03-23 2009-08-27 エフ．ホフマン−ラ ロシュ アーゲー 置換インダゾール誘導体、その製造方法、及びその薬剤としての利用法
US8063225B2 (en) 2006-08-14 2011-11-22 Chembridge Corporation Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
DK2170930T3 (da) 2007-06-04 2012-11-05 Synergy Pharmaceuticals Inc Agonister af guanylatcyclase, anvendelige til behandlingen af gastrointestinale sygdomme, inflammation, cancer og andre sygdomme
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
RU2443704C1 (ru) * 2010-10-29 2012-02-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" СУЛЬФАТЫ 2-АРИЛ-4-ДИАЛКИЛАМИНОЭТИЛ-3-ФЕНИЛПИРРОЛО[1,2-a]-БЕНЗИМИДАЗОЛОВ, ОБЛАДАЮЩИЕ АНТИОКСИДАНТНЫМИ И АНТИРАДИКАЛЬНЫМИ СВОЙСТВАМИ
ES2664873T3 (es) 2011-03-01 2018-04-23 Synergy Pharmaceuticals Inc. Proceso de preparación de agonistas de guanilato ciclasa C
MX2015003330A (es) 2012-09-13 2015-06-05 Hoffmann La Roche 2-oxo-2,3-dihidro-indoles para el tratamiento de trastornos del sistema nervioso central (cns).
EP2958577A2 (fr) 2013-02-25 2015-12-30 Synergy Pharmaceuticals Inc. Agonistes du recepteur de la guanylate cyclase pour l'utilisation dans l'irrigation du colon
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
KR102272746B1 (ko) 2013-06-05 2021-07-08 보슈 헬스 아일랜드 리미티드 구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법
KR20220147691A (ko) 2013-08-09 2022-11-03 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
GB201709456D0 (en) * 2017-06-14 2017-07-26 Ucb Biopharma Sprl Therapeutic agents
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス， インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ
JP6854953B1 (ja) 2020-06-16 2021-04-07 株式会社ソディック ワイヤ放電加工装置

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1158532A (en) * 1967-01-05 1969-07-16 Centre Nat Rech Scient 2-Oxoindoline-3-Carboxylic Acids and Esters thereof
BE714717A (fr) * 1967-05-12 1968-09-30
FR1529901A (fr) * 1967-05-12 1968-06-21 Centre Nat Rech Scient Procédé de préparation de lactames se rattachant à l'indolinone et à l'oxo quinoléine
US4322533A (en) * 1980-03-17 1982-03-30 Lesher George Y 1H-Indole-2,3-dione derivatives
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
DE3224512A1 (de) * 1982-07-01 1984-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazolderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel
GR851085B (fr) * 1984-05-12 1985-11-25 Boehringer Mannheim Gmbh

Also Published As

Publication number Publication date
AU4222285A (en) 1985-11-14
DE3582447D1 (de) 1991-05-16
PL253246A1 (en) 1986-08-26
EP0161632B1 (fr) 1991-04-10
DK209585A (da) 1985-11-13
JPH0772185B2 (ja) 1995-08-02
KR850008170A (ko) 1985-12-13
FI851869L (fi) 1985-11-13
NO851862L (no) 1985-11-13
AU560349B2 (en) 1987-04-02
FI81351B (fi) 1990-06-29
US4666923A (en) 1987-05-19
PT80425B (de) 1987-04-16
EP0161632A2 (fr) 1985-11-21
GR851085B (fr) 1985-11-25
KR870001201B1 (ko) 1987-06-20
ES542976A0 (es) 1986-01-01
PL147842B1 (en) 1989-08-31
SU1480770A3 (ru) 1989-05-15
ES8603178A1 (es) 1986-01-01
PL144822B1 (en) 1988-07-30
JPH0741474A (ja) 1995-02-10
NZ212005A (en) 1989-07-27
EP0161632A3 (en) 1986-06-11
US4963686A (en) 1990-10-16
JPH0647593B2 (ja) 1994-06-22
JPS60246386A (ja) 1985-12-06
PT80425A (de) 1985-06-01
DK209585D0 (da) 1985-05-10
HUT37938A (en) 1986-03-28
PH22863A (en) 1989-01-19
IL75120A0 (en) 1985-09-29
IL75120A (en) 1989-02-28
HU193754B (en) 1987-11-30
FI851869A0 (fi) 1985-05-10

Similar Documents

Publication Publication Date Title
FI81351C (fi) Foerfarande foer framstaellning av farmakologiskt aktiva 2-pyridylsubstituerade 6,7-dihydro-3h,5h-pyrrolo/ 2,3-f/bentsimidazol-6-oner och -6-tioner.
AU746586B2 (en) Quinazolinone inhibitors of cGMP phosphodiesterase
FI66604B (fi) Foerfarande foer framstaellning av nya 5h-2,3-bensodiazepinderivat med inverkan pao det centrala nervsystemet
EP1910379B1 (fr) Promédicaments d'inhibiteurs de la caspase
CA1216291A (fr) Composes d'imidazoquinoxaline
IE901258L (en) Pyrimidine derivatives
AU2018274378B2 (en) Compound used as autophagy regulator, and preparation method therefor and uses thereof
JPH0784470B2 (ja) 活性化合物、その製法及びそれを含む医薬組成物
US4695567A (en) Pyrrolobenzimidazoles, pharmaceutical compositions containing them and method of using them to treat certain heart and circulatory diseases
AU744540B2 (en) 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, addition salts thereof, and processes for the preparation of both
US4863945A (en) Pyrrolobenzimidazoles and pharmaceutical compositions containing them
JPS63192773A (ja) 三環式ベンズイミダゾール、その製法および該化合物を含有する血流障害治療剤
EP0263352A1 (fr) Imidazo-benzoxazinones, leur préparation et médicaments contenant ces composés
FI93444C (fi) Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
US4874756A (en) Benzodipyrroles, processes for the preparation thereof and pharmaceutical compositions containing them
JPH0471914B2 (fr)
IE63043B1 (en) Cyclic amides
NO873108L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-benzodiazepiner.
US4539400A (en) Pyridin-3-yl substituted ortho-fused pyrrole derivatives
US4831032A (en) Cardiotonic benzimidazoles
PT86154B (pt) Processo para a preparacao de novos pirrolobenzimidazoles e de composicoes farmaceuticas que os contem
US4372956A (en) 5, 10-Dihydroimidazo[2,1-b]quinazolines and pharmaceutical compositions containing them
DD234867A5 (de) Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
Kovač et al. New synthesis of 11‐acyl‐5, 11‐dihydro‐6H‐pyrido [2, 3‐b][1, 4]‐benzodiazepin‐6‐ones and related studies
WO2000050420A1 (fr) Derives d'acide 7-heteroquinoxaline carboxilique 6-substitue et leurs sels d'addition, procedes de preparation de ces derives et de leurs sels d'addition

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: BOEHRINGER MANNHEIM GMBH